The French National Agency for the Safety of Medicines and Health Products (ANSM) has authorised FineHeart to commence a ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation to BiVACOR’s titanium Total Artificial ...

Recent FDA updates in the areas of cardiac intervention, hypertension and arrhythmia disorders expand the pool of available ...

AI tools are effective for detecting left ventricular systolic dysfunction among women of reproductive age seen in primary care.

"Now, the WiSE System brings a leadless solution to left ventricular pacing ... The WiSE System syncs with existing pacing devices—pacemakers, ICDs, or CRTs—using a subcutaneous ultrasound ...

The US Food & Drug Administration has approved EBR System’s leadless pacemaker WISE, the only device able to deliver left-ventricle stimulation. Ecstatic CEO John McCutcheon said the FDA's ...

The US Food & Drug Administration has approved EBR System’s leadless pacemaker WISE, the only device able to deliver left-ventricle stimulation. Don't miss out on the headlines from Stockhead.

Nat Clin Pract Cardiovasc Med. 2006;3(7):346-347. Since the first widespread clinical application of left ventricular assist devices (LVADs) for patients with end-stage heart failure in the ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

The program helps patients with end-stage heart failure get left ventricular assist devices, commonly known as LVADs. The mechanical pump is surgically implanted and is often used as a bridge for ...

Testing of the device has been done by connecting it ... More information: James Davies et al, Soft robotic artificial left ventricle simulator capable of reproducing myocardial biomechanics ...